WeissKBSullivanSDLyttleCS. Trends in the cost of illness for asthma in the United States, 1985–1994. J Allergy Clin Immunol2000;106: 493–9.
2.
WeissKBSullivanSD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol2001;107: 3–8.
3.
National Asthma Education and Prevention Program Task Force report on the cost effectiveness, quality of care, and financing of asthma care. Am J Respir Crit Care Med1996;154(Suppl):S81–130.
4.
Measuring childhood asthma prevalence before and after the 1997 redesign of the National Health Interview Survey — United States. MMWR Morb Mortal Wkly Rep2000;49: 908–11.
5.
CDC. Surveillance for asthma — United States. MMWR Morb Mortal Wkly Rep1998;47(SS-1).
6.
StreetmanDDBhatt-MehtaVJohnsonCE. Management of acute severe asthma. Ann Pharmacother2002;36: 1249–60.
7.
Physicians' desk reference. PDR Electronic Library, Medical Economics, Release 2001.1AX, January, 2001.
National Asthma Education and Prevention Program Expert Panel report 2: guidelines for the diagnosis and management of asthma. NIH publication no. 97–4051. Bethesda, MD: US Department of Health and Human Services, 1997.
10.
LotvallJPalmqvistMArvidssonPMaloneyAVentrescaPWardJ. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol2001;108: 726–31.
11.
RoweBHBretzlaffJABourdonCBotaGWCamargoCAJr.Magnesium sulfate for treating exacerbations of acute asthma in the emergency department (Cochrane Review). In: The Cochrane Library, Issue 1, Oxford, UK, 2000.
12.
CiaralloLSauerAHShannonMW. Intravenous magnesium therapy for moderate to severe pediatric asthma: Results of a randomized, placebo-controlled trial. J Pediatr1996;129: 809–14.
13.
CiaralloLBrosseauDReinertS. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med2000;154: 979–83.
14.
KellyHWMurphySJ. The management of acute severe asthma in children. In: BusseWWHolgateS, eds. Asthma and rhinitis. Boston: Blackwell Science, 2000: 1944–60.
RoweBHAldersonP. The Cochrane Collaboration: A resource for clinical problem solving in emergency medicine. Ann Emerg Med1999;4: 86–90.
18.
RoweBHKellerJLOxmanAD. Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis. Am J Emerg Med1992;10: 301–10.
19.
PlotnickLHDucharmeFM. Should inhaled anticholinergics be added to β2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ1998;317: 971–7.
20.
RoweBHBretzlaffJABourdonCBotaGWCamargoCAJr.Intravenous magnesium sulfate treatment for acute asthma in the emergency department: A systematic review of the literature. Ann Emerg Med2000;36: 181–90.
NCI, Research Contracts Branch. IV magnesium for treating acute, severe asthma exacerbations (MASA), RFP N01-AT-11022-64 [cited 2002 Jan 25]. Available from: URL: http://rcb.nci.nih.gov/appl/rfp/11022/.
23.
RobertsonCFRubinfeldARBowesG. Pediatric asthma deaths in Victoria: The mild are at risk. Pediatr Pulmonol1992;13: 95–100.
24.
HilliardTNWittenHMaleIAHewerSLSeddonPC. Management of acute childhood asthma: A prospective multicentre study. Eur Respir J2000;15: 1102–5.
25.
PressSLipkindRS. A treatment protocol of the acute asthma patient in a pediatric emergency department. Clin Pediatr1991;30: 573–7.
26.
McFaddenERJr.ElsanadiNDixonLTakacsMDealECBoydKKProtocol therapy for acute asthma: Therapeutic benefits and cost savings. Am J Med1995;99: 651–61.
27.
JohnsonKBBlaisdellCJWalkerAEgglestonP. Effectiveness of a clinical pathway for inpatient asthma management. Pediatrics2000;106: 1006–12.